Dose Adjustment Helps Obtain Better Outcomes in Multiple Myeloma Patients with Bortezomib, Melphalan, and Prednisolone (VMP) Treatment

Su-Hee Cho Ho Jin Shin Ki Sun Jung Do Young Kim

Published in: Turkish journal of haematology : official journal of Turkish Society of Haematology (2019)

Active dose reduction helped to continue treatment and it increased the opportunity to be exposed to drugs. In the end, it resulted in improved outcome.

Keyphrases

multiple myeloma
high dose
type diabetes
combination therapy
weight loss